Narmada Gelatine (526739)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 1/1

Key Financials

Current Price₹388.85
Market Cap₹241.03 Cr
P/E Ratio8.87
ROCE19.92%
ROE21.88%
Dividend Yield2.82%
Profit Growth72.9%
Debt/Equity—
Sales Growth18.14%
52-Week Range₹330 — ₹460
SectorChemicals & Petrochemicals
Book Value₹183.09

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Looking at Narmada Gelatine, I first ask: what does the business earn on capital? The answer is pleasing. ROE of 21.88% and ROCE of 19.92% tell me this specialty chemical company puts shareholder money to work efficiently. At ₹388.85, the market caps the company at ₹241 Cr, which is only 8.87 times trailing earnings. For a business growing sales at 18.14% and profits at 72.90%, that price is not demanding. The latest quarter — ₹57 Cr sales and ₹7 Cr net profit — suggests momentum is intact. A Piotroski F-Score of 7 out of 9 adds further confidence in the financial health. Benjamin Graham would like the margin of safety: the earnings yield is over 11%, and the 2.82% dividend yield gives me a small reward while waiting. That said, I must not mistake a good price for a sure thing. The 52-week range of ₹327.30 to ₹460.00 shows this is not a quiet stock; it can swing. Debt/equity is not provided, and promoter holding is also marked N/A, so I am flying partially blind. A P/B of 2.12 means I am paying a premium to book value, so I must rely on the company maintaining its high returns. Still, with a PEG of 0.19, the market seems to be ignoring Narmada's growth. My style is to buy wonderful businesses at fair prices; here I may be getting a decent business at a very reasonable price. I would not bet the farm on one quarter, but I would keep this on my watch list and study the full annual report before acting.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer